What is Bonesupport Holding AB (publ)?
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BOEUF · Verdict
Strong reward · low risk
BOEUF scores well on profitability and cash flow with no major weaknesses flagged in the model.
Based on 88% data coverage
BOEUF · Verdict
12% net margin · 22% ROE
19% free-cash-flow margin
Revenue +52.7% CAGR
Top decile vs peers
Current ratio 4.85
Model-based scoring. For information only — not financial advice.
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.57B, and a P/E ratio of 79.3x.
The scoring profile indicates a strong reward potential, driven primarily by profitability and growth. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.